J&J Expands Damages In Express2 Injunction Bid; BSC Adds Counterclaims
This article was originally published in The Gray Sheet
Executive Summary
Claims made by Johnson & Johnson/Cordis' legal counsel arguing a patent infringement case against Boston Scientific/Scimed may be further buttressed by previous actions taken by a Delaware district court
You may also be interested in...
Medinol Pursuing Injunction Against Boston Scientific German Stent Sales
Boston Scientific will skirt a potential injunction against its German subsidiary's stent sales by supplying the market directly through the parent company, the firm says
Medinol Pursuing Injunction Against Boston Scientific German Stent Sales
Boston Scientific will skirt a potential injunction against its German subsidiary's stent sales by supplying the market directly through the parent company, the firm says
J&J, Medtronic Play The Slots Before Appeals Court In Stent Patent Debate
Bare-metal stent intellectual property litigation between Johnson & Johnson/Cordis and Medtronic AVE presented before the Washington, D.C. federal appeals court May 6 hinges on the manufacturing method used to create holes in the devices